Results 1 to 10 of about 20 (20)
El metotrexato (MTX) es un antagonista del ácido fólico usado como quimioterápico en las neoplasias hematológicas. El 50% del MTX se liga a las proteínas plasmáticas y el 90% de su eliminación a las 24 horas es por vía renal. Sin embargo, entre los efectos adversos principales se encuentra la insuficiencia renal, lo que condiciona su acumulación y ...
Pablo A. Llerena-Rengel +2 more
openaire +2 more sources
Labial Frenectomy using Laser: A Scoping Review
Labial frenectomy is a surgical technique, that aims to remove the frenulum with its attachment to the underlying bone. Frenectomy, is indicated if the frenulum attachment causes midline diastema, gingival recession, hindrance in maintaining oral hygiene, or if it interferes with lip movements and for prosthetic needs.
Mario Dioguardi +10 more
wiley +1 more source
The noncarious cervical lesions (NCCLs) recognize an etiological framework of onset very different from the carious processes with etiology whose bacteria aggregated in a biofilm play a predominant role, leading in this way to the loss of the mineralized structure of the tooth.
Mario Dioguardi +9 more
wiley +1 more source
Global real‐world data on hemodiafiltration: An opportunity to complement clinical trial evidence
Abstract Hemodiafiltration (HDF) is a renal replacement therapy that utilizes both diffusive clearance and convective transport to achieve greater clearance of middle‐molecular‐weight solutes. Among other factors, important prerequisites for the implementation of HDF include access to high‐flux dialyzers, achievement of high blood flow rates, and ...
Linda H. Ficociello +3 more
wiley +1 more source
Recent advances in pharmacological treatment of heart failure
Abstract Background Over the last years, several trials offered new evidence on heart failure (HF) treatment. Design and results For HF with reduced left ventricular ejection fraction, type 2 sodium—glucose cotransporter inhibitors, aside from sacubitril—valsartan, demonstrated extraordinary efficacy in ameliorating patients' prognosis.
Massimo Iacoviello +2 more
wiley +1 more source
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single‐Center Study
Background. Although diabetic kidney disease (DKD) could affect up to one‐third of patients with diabetes mellitus (DM), these patients can develop kidney diseases different from DKD, or these conditions can superimpose on DKD. Several potential predictors of nondiabetic kidney disease (NDKD) have been proposed, but there are no definitive indications ...
Francesco Fontana +8 more
wiley +1 more source
Abstract Aims Long‐term treatment effect studies in large female Fabry patient groups are challenging to design because of phenotype heterogeneity and lack of appropriate comparison groups, and have not been reported. We compared long‐term cardiomyopathy and kidney function outcomes after agalsidase beta treatment with preceding treatment‐naive ...
Christoph Wanner +15 more
wiley +1 more source
This guideline addresses the treatment of umbilical and epigastric hernias in clinically challenging situations (cirrhosis, dialysis, subsequent pregnancy, rectus diastasis), as well as the treatment of Spigelian and primary lumbar hernias. Emphasises the need for better evidence Background Rare locations of hernias, as well as primary ventral hernias ...
N. A. Henriksen +12 more
wiley +1 more source
Renal Volume in ADPKD Patient Evaluation
The clinical manifestations of ADPKD are related to the growth of renal cysts. Renal volume has been recognised as the biomarker that is able to identify those patients at risk of complications (hypertension and haematuria) and at risk of progression to End Stage Renal Disease (ESRD).
M. Galliani +8 more
wiley +1 more source
Objective. To determine the oxidative stress/inflammation behavior in patients with/without acute graft dysfunction (AGD) with Tacrolimus. Methods. Cross‐sectional study, in renal transplant (RT) recipients (1‐yr follow‐up). Patients with AGD and without AGD were included.
Sandra Carrillo-Ibarra +8 more
wiley +1 more source

